We are committed to connecting with rare disease focused patient advocacy groups to guide them towards readiness for natural history studies or the clinical trial phase. As a 501(c)(3) non-profit corporation, our mission is to help prepare patient advocacy groups for clinical trials. Global Genes™ is a leading rare disease patient advocacy organization. The Foundation’s mission is to unify the international rare disease community by providing connections and resources to ease the burdens of affected patients and their families. Recognized worldwide by the Blue Denim Genes Ribbon™, Global Genes unites experts, advocates and patients of all ages to stand together in hope for treatments and cures for the estimated 7,000 rare and diseases that impact approximately 30 million Americans and over 350 million people worldwide. Projecis is a content management and data visualization platform that enables project stakeholders to connect teams, organize data, and disseminate information for better business decision-making. It provides researchers with a centralized, international patient registry for all rare diseases.
Carlsbad, United States
Founded in 2017
1-10 Employees
Working industry
Other
Type of company
-
Ownership structure
Nonprofit
Locations
1 Headquarter
Specialised areas
Working with and for Patient Advocacy Groups, Retrospective Chart Review, Develop and Support Registries, Natural History Studies, Pairing Patients with Registries, Pairing Sponsors with Trials, Finding Patients for Sponsors, Advocate Rare Disease Legislation, Prospective Study Management, Non-profit Organization Management
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
United States
Overall risk estimation:
Low
The ESG Data of countries are based on public sources
Environment
D
Grade (A-E)
View details
Social
A
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
PROS Foundation -Pathways for Rare and Orphan Studies operates in 1 country around the world
Get an overview of the locations of PROS Foundation -Pathways for Rare and Orphan Studies
Location
Country
State
City
Headquarter
United States
California
Carlsbad
Some frequent questions that have been asked about PROS Foundation -Pathways for Rare and Orphan Studies
Where is PROS Foundation -Pathways for Rare and Orphan Studies located?
The company headquarter of PROS Foundation -Pathways for Rare and Orphan Studies is located in Carlsbad, California, United States. It's worth noting, that the company may have more locations
How many employees does PROS Foundation -Pathways for Rare and Orphan Studies approximately have?
As of the latest available information PROS Foundation -Pathways for Rare and Orphan Studies has around 1-10 employees worldwide.
When was PROS Foundation -Pathways for Rare and Orphan Studies founded?
PROS Foundation -Pathways for Rare and Orphan Studies was founded in 2017
In which industries does PROS Foundation -Pathways for Rare and Orphan Studies mainly work?
The company PROS Foundation -Pathways for Rare and Orphan Studies has it's main focus in the industries of Other
Check out some interesting alternative companies to PROS Foundation -Pathways for Rare and Orphan Studies
H4B Boston
Boston, United States
11-50 Employees
2012
We are proud to be a Gold sponsor of the 2023 WOD Congress, the world’s most important orphan drug and rare disease event! We are a member of Global Genes and its RARE Corporate Alliance, a partnership of rare disease industry stakeholders committed to forging and supporting collaboration between industry and patient communities. We are proud to showcase the work of Kam Redlawsk on our walls at H4B Boston.
Cure Rare Disease
Boston, United States
1-10 Employees
2017
Through collaborations with world-renowned academics and clinicians, we are moving science forward to develop life-saving gene therapies for rare and ultra-rare disease patients overlooked and underserved by traditional drug development efforts. Our collaborative framework reimagines the drug development process to provide an accelerated pathway for the development of life-saving therapeutics that previously did not exist for people with rare and ultra-rare neuromuscular diseases. Moreover, our model offers industry collaborators a mechanism to expand their drug development pipeline. As the scope of our research and development grows, so does our need to expand our network of collaborators to advance therapeutics for rare and ultra-rare neuromuscular diseases, speed drug development for orphan diseases, and expand access to treatments to broader populations.
Clinic for Special Children
Strasburg, United States
11-50 Employees
1989
We are a dedicated team of physicians, nurses, scientific researchers, administrative staff, and patient advocates working to provide comprehensive medical care, integrate science and clinical medicine, and share insights to improve the health of children and adults facing rare genetic disorders. From our humble beginnings, we have provided a medical home for children and adults with rare genetic conditions. For over 35 years, we have been steadfast in our mission of providing efficient and affordable healthcare to vulnerable individuals with genetic diseases. Our collaborations help us provide affordable specialty care on-site at the Clinic, making services more accessible to families. Our clinic serves as a trusted medical home for families working to prevent and treat genetic illness in their children. Our clinic serves as a trusted medical practice for children and adults facing rare genetic disorders. Inside is filled with cutting-edge gene sequencing tools that allow us to deliver highly personalized care—a precise treatment option for the right patient at the right time.
TMA Precision Health
Boston, United States
1-10 Employees
2019
OUR MISSION is to help rare disease patients by ending their diagnostic odyssey. Our research platform will let you and your provider look up all the known information about your diagnosed disease in minutes - related genes, repurposed drugs, existing care, and active clinical trials. Our platform is built to help you navigate the most challenging cases.
Rare Diseases Clinical Research Network (RDCRN)
Cincinnati, United States
251-500 Employees
-
The devastating impact of COVID-19 on the general population is well-documented—but less is known about the millions of people living with rare diseases. Our network, now in its fourth five-year funding cycle, is a partnership with funding and programmatic support provided by Institutes, Centers and Offices across NIH.
Raremark
London, United Kingdom
- Employees
-
At RareDisease.net we empower patients and caregivers to take control of rare diseases by providing a platform to learn, educate, and connect with peers and healthcare professionals. RareDisease.net can have an enormous impact on the lives of patients and their loved ones. At RareDisease.net, we strive to provide you with the most accurate and relevant information. RareDisease.net also features articles contributed by Physicians, Patient Advocates or other Healthcare Experts. RareDisease.net does not edit these articles, as they represent the thoughts, opinions, and judgment of their authors. RareDisease.net accepts responsible advertising and sponsorships, however sponsors do not influence editorial content in any way. RareDisease.net is brought to you by Health Union, LLC, which does not manufacture, distribute, market or sell any product to cure, diagnose or prevent rare diseases or any health condition. Although there is no cure for rare diseases, we hope the information provided by patients, caregivers, and healthcare professionals at RareDisease.net will help improve your quality of life.